Feng, S., Feng, Z., Xie, S., Zhou, Y., Sun, W., Lin, N., Lin, Z., Wang, Q., Zhao, Z., Lin, Y., Long, H.

Plasma proteomics predicts pathological complete response and reveals LIF as a potential mediator of resistance to neoadjuvant immunochemotherapy in resectable NSCLC

9 de July de 2026 by Feng, S., Feng, Z., Xie, S., Zhou, Y., Sun, W., Lin, N., Lin, Z., Wang, Q., Zhao, Z., Lin, Y., Long, H.

Background
Neoadjuvant immunochemotherapy (nICT) is increasingly used for resectable non-small cell lung cancer (NSCLC), yet a substantial proportion of patients fail to achieve pathological complete response (pCR). Clinically scalable, minimally inva…